Can hormones
make ADHD worse?

Yes, and this is one of the most underrecognized aspects of ADHD in women. A growing body of research confirms that hormonal fluctuations can significantly worsen ADHD symptoms, affect mood and sleep, and even reduce the effectiveness of ADHD medication.

The Menstrual Cycle and ADHD

A 2025 review in European Psychiatry found that hormonal fluctuations significantly impact women with ADHD, affecting symptom severity, mood, sleep, and treatment efficacy. Many women report cyclical variations in ADHD symptom intensity, with worsening during the late luteal phase (the week before menstruation) and improvement during the follicular phase (after menstruation begins).

A narrative review of 29 studies examining cognitive functioning across the menstrual cycle found that while non-clinical populations showed enhanced attentional processing during the mid-luteal phase, women with ADHD consistently showed impairments in attention, executive function, and impulsivity during the mid-luteal and premenstrual phases. These objective findings parallel subjective reports of worsened cognition and diminished medication efficacy during the luteal phase.

A large survey of 600 women with ADHD confirmed these patterns: 88.6% of premenopausal participants not taking hormonal therapy reported changes in ADHD symptoms across the menstrual cycle, with most reporting worsening during the luteal phase.

The Biological Mechanism

A novel theoretical framework proposes that women with ADHD experience a "double whammy" of hormonal effects. Estrogen has well-documented effects on dopamine neurotransmission, the same neurotransmitter system implicated in ADHD. When estrogen levels drop rapidly, as they do premenstrually and during the perimenopausal transition, dopamine signaling may be further compromised in a brain already vulnerable due to ADHD.

The theory proposes that rapid declines in estrogen decrease executive function and behavioral control at two points in the cycle: mid-cycle (periovulatory), when approach and risk-taking behaviors may increase, and perimenstrually, when negative affect and inattention may worsen. These interactions may be exacerbated by the organizational effects of puberty on brain circuitry.

Postpartum and Perimenopause

The impact of hormones extends beyond the menstrual cycle. In the survey of 600 women with ADHD, 70.4% perceived a worsening of ADHD symptoms during the postpartum period, and 97.5% reported worsening during menopause. These are periods of dramatic hormonal change, particularly in estrogen and progesterone, and they represent critical windows of vulnerability for women with ADHD.

Clinical Implications

The failure to recognize hormone-related ADHD symptom fluctuations has contributed to underdiagnosis and misdiagnosis of ADHD in women, as well as suboptimal treatment. Practical recommendations from clinical experts include:

• Menstrual cycle tracking: Women with ADHD should track their symptoms across the menstrual cycle to identify patterns of worsening.
• Medication adjustment: Some clinicians adjust stimulant dosing during the luteal phase, though more research is needed to establish standardized protocols.
• Hormonal status assessment: Considering hormonal status, including menstrual phase, postpartum status, and perimenopausal transition, should be part of ADHD diagnosis and ongoing management in women.
• Comorbidity screening: Hormonal fluctuations can exacerbate comorbid anxiety and depression, which should be monitored and treated.

If you notice that your ADHD symptoms worsen at predictable points in your cycle, you are not imagining it. Discuss these patterns with your healthcare provider; this information can meaningfully improve your treatment.